Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009571
Filing Date
2025-05-12
Accepted
2025-05-12 08:05:27
Documents
76
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 912176
2 EX-31.1 ex31-1.htm EX-31.1 17445
3 EX-31.2 ex31-2.htm EX-31.2 17627
4 EX-32.1 ex32-1.htm EX-32.1 8283
5 EX-32.2 ex32-2.htm EX-32.2 8122
  Complete submission text file 0001641172-25-009571.txt   5860748

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nrxs-20250331.xsd EX-101.SCH 43337
7 XBRL CALCULATION FILE nrxs-20250331_cal.xml EX-101.CAL 67994
8 XBRL DEFINITION FILE nrxs-20250331_def.xml EX-101.DEF 181673
9 XBRL LABEL FILE nrxs-20250331_lab.xml EX-101.LAB 439711
10 XBRL PRESENTATION FILE nrxs-20250331_pre.xml EX-101.PRE 349947
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 783594
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41775 | Film No.: 25932691
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)